Analysis of the nuclear distribution of the translocation t(8;21)-derived fusion protein AML1/ETO by confocal laser scanning microscopy

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 2, 2002, Pages 401-408

  Nagel, Stefan ^a   Hambach, Lothar ^a   Krauter, Jürgen ^a   Venturini, Letitia ^a   Heidenreich, Olaf ^b   Ganser, Arnold ^a   Heil, Gerhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN ETO; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; AML1 ETO FUSION PROTEIN, HUMAN; AML1-ETO FUSION PROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHROMOSOME TRANSLOCATION 8; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; GENE CONSTRUCT; GENE DELETION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; ACTIVE TRANSPORT; CELL LINE; CELL NUCLEUS; CHEMISTRY; CHROMOSOME 21; CHROMOSOME 8; CONFOCAL MICROSCOPY; GENE TRANSLOCATION; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HUMANS; MICROSCOPY, CONFOCAL; NUCLEAR LOCALIZATION SIGNALS; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0036223615     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581602753658583     Document Type: Article

References (31)

1. Structure and function in the nucleus
2. Half a century of "the nuclear matrix"
3. Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions
4. Nuclear structure/gene expression interrelationships
5. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
6. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1
7. Role of SUMO-1-modified PML in nuclear body formation
8. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps 15 translocation partner
9. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AMLI/ETO, with similarity to Drosophila segmentation gene, runt
10. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
11. The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system
12. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions
13. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha
14. Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF
15. Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains
16. Expression of AML1 and ETO transcripts in hematopoietic cells
17. Structure and expression of the human MTG8/ETO gene
18. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue
19. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO
20. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors
21. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein
22. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
23. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
24. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein
25. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
26. The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor
27. Nuclear import and subnuclear localization of the proto-on-coprotein ETO (MTG8)
28. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1
29. Oligomerization of ETO is obligatory for corepressor interaction
30. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies